Evidence map›Paper›PMID 40625744›Full record

ArticleFrontiers in immunology2025

GMMA-based vaccine candidates against invasive nontyphoidal salmonellosis elicit bactericidal antibodies against a panel of epidemiologically relevant

Daniele De Simone, Marika Pinto, Maria Grazia Aruta, Marta Benincasa, Martina Carducci, Roberta Di Benedetto, Francesco Citiulo, Miren Iturriza, Elli Mylona, Stephen Baker and 5 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Multivalent vaccines for invasiveInfection and immunity · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Daniele De SimoneGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Marika PintoGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Maria Grazia ArutaGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Marta BenincasaGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Martina CarducciGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Roberta Di BenedettoGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Francesco CitiuloGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Miren IturrizaGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Elli MylonaCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.
Stephen BakerASTAR Infectious Diseases Labs (ASTAR IDL), Singapore, Singapore.
Mariagrazia PizzaImperial College, London, United Kingdom.
Carlo GiannelliGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Francesca ManciniGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Rocío CanalsGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Omar RossiGSK Vaccines Institute for Global Health (GVGH), Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic disease caused by nontyphoidal

Indexed as

Antibodies, BacterialSalmonella InfectionsSalmonella typhimuriumSalmonella VaccinesAnimalsAntigens, BacterialFemaleHumansMiceO AntigensRabbitsSalmonella enteritidisAntibodies, BacterialAntigens, BacterialO AntigensSalmonella VaccinesbactericidalGMMAiNTSO-antigenSalmonellaSBAvaccine

Identifiers

PMID40625744
PMCPMC12231430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.